Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

Delayed Data
As of Oct 02
 +0.46 / +4.30%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 16.00, with a high estimate of 19.00 and a low estimate of 14.00. The median estimate represents a +43.24% increase from the last price of 11.17.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 20.42%
Growthannually -39.80%


Growthquarterly 70.44%
Growthannually 13.16%
Key to the earnings and sales forecast charts.